What Works Skin — Independent · Evidence-First · Ad-FreeIssue 014 · 20 April 2026 · Next: 04 Maywhatworksskin.com
What WorksSkin
Search/

Supplement · Barrier & inflammation · Evening primrose oil

P. 26 · BRIEF

Evening primrose.

GLA precursor. Mixed eczema data.

Evening primrose oil delivers gamma-linolenic acid (GLA), a precursor to prostaglandins involved in skin barrier function. The eczema literature is mixed: positive in early small trials, less convincing in the larger Cochrane reviews. A safer-than-spectacular molecule with a defensible role in mild atopic skin.

⁂

— § 02

What the literature shows.

Atopic dermatitis (Cochrane review)
Pooled meta-analysis

The 2013 Cochrane review concluded oral evening primrose oil does not meaningfully improve eczema vs placebo. Earlier small trials were more positive.

35%
Atopic dermatitis (small RCTs)
Heterogeneous

Several small positive trials; methodologically weaker. Reasonable trial in mild cases.

50%
Cyclic mastalgia (premenstrual breast pain)
Replicated

Better-supported off-label use than the eczema indication.

65%
Hot flushes / menopause
Mixed

Inconsistent. Not a primary recommendation for menopausal symptoms.

40%
⁂

— § 03

Forms and bioavailability.

EPO 500 mg (45–60 mg GLA)

Absorption · Good

Standard low-dose. Two capsules twice daily for atopic skin trial.

EPO 1000 mg (90–120 mg GLA)

Absorption · Good

Higher per-capsule dose. Useful for hitting the trial protocol with fewer capsules.

Borage oil (higher GLA per capsule)

Absorption · Good

Cheaper alternative source of GLA. Equivalent endpoints in head-to-head trials.

Black currant seed oil

Absorption · Good

Vegetarian / vegan-friendly GLA source. Less-studied than EPO but mechanistically equivalent.

⁂

Bottom line

A modest, safe, defensible adjunct for mild atopic skin; not a primary treatment. The Cochrane verdict is honest; the case for trying it is reasonable.

⁂

— § 04

Frequently asked.

Why is the Cochrane verdict so flat?

The pooled analysis weighted more recent, larger, methodologically tighter trials, which generally showed null or marginal effects. The earlier positive trials had smaller sample sizes and less rigorous methodology. Both data sets exist; we present both honestly.

Should I trial it?

Reasonable in mild atopic skin where the topical-only protocol has plateaued. 12 weeks at the published dose. If no measurable effect, the supplement is not your bottleneck — pivot to topical optimisation, allergen audit, or systemic options if appropriate.

Can I combine with omega-3?

Yes. The two work via partly different prostaglandin pathways; combination is reasonable. Most atopic protocols that include EPO also include 1–2 g EPA+DHA omega-3.

Side effects?

Generally very well-tolerated. Mild GI upset is the most common. Theoretical bleeding-risk concern at high doses with anticoagulants; clinically rarely an issue. Stop one week before elective surgery as a precaution.